Display options
Share it on

Curr Cardiovasc Risk Rep. 2016 Jan;10. doi: 10.1007/s12170-015-0480-3. Epub 2015 Dec 29.

Primary Prevention of Atherosclerotic Cardiovascular Disease in Women.

Current cardiovascular risk reports

Rebeccah A McKibben, Mahmoud Al Rifai, Lena M Mathews, Erin D Michos

Affiliations

  1. Ciccarone Center for the Prevention of Heart Disease, Johns Hopkins University School of Medicine, Baltimore, MD, USA 21287.

PMID: 28149430 PMCID: PMC5279938 DOI: 10.1007/s12170-015-0480-3

Abstract

Atherosclerotic cardiovascular disease (ASCVD) is the leading cause of morbidity and mortality among women. Despite improvements in cardiovascular disease prevention efforts, there remain gaps in cardiovascular disease awareness among women, as well as age and racial disparities in ASCVD outcomes for women. Disparity also exists in the impact the traditional risk factors confer on ASCVD risk between women and men, with smoking and diabetes both resulting in stronger relative risks in women compared to men. Additionally there are risk factors that are unique to women (such as pregnancy-related factors) or that disproportionally affect women (such as auto-immune disease) where preventive efforts should be targeted. Risk assessment and management must also be sex-specific to effectively reduce cardiovascular disease and improve outcomes among women. Evidence supports the use of statin therapy for primary prevention in women at higher ASCVD risk. However, some pause should be given to prescribing aspirin therapy in women without known ASCVD, with most evidence supporting the use of aspirin for women≥65 years not at increased risk for bleeding. This review article will summarize (1) traditional and non-traditional assessments of ASCVD risk and (2) lifestyle and pharmacologic therapies for the primary prevention of ASCVD in women.

Keywords: Cardiovascular Disease; Prevention; Risk; Women

Conflict of interest statement

Compliance with ethics guidelines Conflict of interest Rebeccah McKibben, Lena Mathews, Mahmoud Al Rifai and Erin Michos have no relevant disclosures to report.

References

  1. Arthritis Rheum. 2001 Dec;44(12):2737-45 - PubMed
  2. BMJ Open. 2014 Dec 30;4(12 ):e005663 - PubMed
  3. Arch Intern Med. 2003 Jul 28;163(14):1735-40 - PubMed
  4. Am J Epidemiol. 2008 Apr 1;167(7):875-81 - PubMed
  5. Health Care Women Int. 2008 Jan;29(1):3-22 - PubMed
  6. Circulation. 1983 May;67(5):968-77 - PubMed
  7. Eur J Prev Cardiol. 2012 Oct;19(5):1138-44 - PubMed
  8. BJOG. 2014 Nov;121(12):1530-6 - PubMed
  9. Arch Intern Med. 2001 May 14;161(9):1183-92 - PubMed
  10. Circulation. 1996 Feb 1;93(3):450-6 - PubMed
  11. Arch Intern Med. 2012 Jun 25;172(12):909-19 - PubMed
  12. Eur J Epidemiol. 2013 Jan;28(1):1-19 - PubMed
  13. J Am Coll Cardiol. 2006 May 2;47(9):1741-53 - PubMed
  14. Stroke. 2009 Jul;40(7):2502-6 - PubMed
  15. N Engl J Med. 2005 Mar 31;352(13):1293-304 - PubMed
  16. J Clin Endocrinol Metab. 2010 Feb;95(2):772-8 - PubMed
  17. Climacteric. 2007 Feb;10 Suppl 1:19-24 - PubMed
  18. Circ Cardiovasc Qual Outcomes. 2011 Mar;4(2):253-6 - PubMed
  19. Arterioscler Thromb Vasc Biol. 2000 Aug;20(8):1932-8 - PubMed
  20. Ann Intern Med. 2015 Feb 17;162(4):266-75 - PubMed
  21. Circulation. 1999 Mar 9;99(9):1165-72 - PubMed
  22. JAMA. 2007 Apr 4;297(13):1465-77 - PubMed
  23. Am J Epidemiol. 2007 Dec 15;166(12):1431-7 - PubMed
  24. J Am Coll Cardiol. 2007 Nov 27;50(22):2128-32 - PubMed
  25. Heart. 2015 Mar;101(5):369-76 - PubMed
  26. Lancet. 2009 May 23;373(9677):1773-9 - PubMed
  27. N Engl J Med. 2007 Jun 7;356(23):2388-98 - PubMed
  28. Circulation. 2014 Jun 24;129(25 Suppl 2):S76-99 - PubMed
  29. J Am Coll Cardiol. 2009 Dec 15;54(25):2366-73 - PubMed
  30. Circulation. 2005 Mar 15;111(10):1321-6 - PubMed
  31. J Am Coll Cardiol. 2014 May 13;63(18):1815-22 - PubMed
  32. Circ Cardiovasc Qual Outcomes. 2014 May;7(3):453-60 - PubMed
  33. Arch Intern Med. 2009 Oct 26;169(19):1762-6 - PubMed
  34. Am J Pathol. 2008 Sep;173(3):600-9 - PubMed
  35. Eur J Cardiovasc Prev Rehabil. 2009 Apr;16(2):174-9 - PubMed
  36. Circulation. 2015 Jan 20;131(3):227-9 - PubMed
  37. Circulation. 1998 Oct 6;98(14):1472-6 - PubMed
  38. JAMA. 2004 May 12;291(18):2204-11 - PubMed
  39. Circulation. 2014 Jan 21;129(3):e28-e292 - PubMed
  40. J Clin Endocrinol Metab. 1999 Jan;84(1):165-9 - PubMed
  41. Cardiology. 2015;130(1):62-8 - PubMed
  42. J Clin Endocrinol Metab. 2004 Sep;89(9):4588-93 - PubMed
  43. Circulation. 2012 Jan 3;125(1):e2-e220 - PubMed
  44. Hypertension. 2011 Jul;58(1):57-62 - PubMed
  45. JAMA. 2014 Apr 9;311(14):1416-23 - PubMed
  46. Circulation. 2011 Mar 22;123(11):1243-62 - PubMed
  47. Lancet. 2005 Nov 19;366(9499):1797-803 - PubMed
  48. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2889-934 - PubMed
  49. Am J Cardiol. 2011 Jan 15;107(2):325-30 - PubMed
  50. Obstet Gynecol. 2009 Nov;114(5):1076-84 - PubMed
  51. JAMA Intern Med. 2014 Dec;174(12):1964-71 - PubMed
  52. Circulation. 2011 Jan 4;123(1):104-23 - PubMed
  53. Ann Intern Med. 1977 Oct;87(4):393-7 - PubMed
  54. Circ Cardiovasc Qual Outcomes. 2015 May;8(3):244-51 - PubMed
  55. N Engl J Med. 2005 Aug 4;353(5):468-75 - PubMed
  56. J Clin Endocrinol Metab. 2005 May;90(5):2718-24 - PubMed
  57. Eur J Epidemiol. 2011 Oct;26(10):771-8 - PubMed
  58. Circulation. 2009 Apr 14;119(14):1892-8 - PubMed
  59. Am Heart J. 2009 Oct;158(4):554-61 - PubMed
  60. N Engl J Med. 1993 May 27;328(21):1528-33 - PubMed
  61. Hypertension. 2001 May;37(5):1199-208 - PubMed
  62. Hypertens Res. 2012 Mar;35(3):251-60 - PubMed
  63. Am J Epidemiol. 1997 Mar 1;145(5):408-15 - PubMed
  64. Arterioscler Thromb Vasc Biol. 2000 Nov;20(11):2414-21 - PubMed
  65. Am J Cardiol. 2007 Aug 1;100(3):409-14 - PubMed
  66. JAMA. 2003 Sep 24;290(12):1600-7 - PubMed
  67. Metabolism. 1995 Sep;44(9 Suppl 3):15-7 - PubMed
  68. Am J Epidemiol. 2014 Jul 1;180(1):29-40 - PubMed
  69. BMJ. 2006 Jan 14;332(7533):73-8 - PubMed
  70. N Engl J Med. 2012 Jan 26;366(4):321-9 - PubMed
  71. Int J Obes (Lond). 2013 Aug;37(8):1036-43 - PubMed
  72. N Engl J Med. 2008 May 8;358(19):1991-2002 - PubMed
  73. Maturitas. 2001 Aug 25;39(2):125-32 - PubMed
  74. Circ Cardiovasc Qual Outcomes. 2010 Mar;3(2):120-7 - PubMed
  75. Ann Intern Med. 2015 Jan 20;162(2):123-32 - PubMed
  76. JAMA. 1996 Jul 17;276(3):205-10 - PubMed
  77. Am Heart J. 2015 Mar;169(3):387-395.e3 - PubMed
  78. Circulation. 2010 Mar 9;121(9):1069-77 - PubMed
  79. J Am Coll Cardiol. 2005 Aug 2;46(3):464-9 - PubMed
  80. Circulation. 2015 Feb 17;131(7):614-23 - PubMed
  81. J Am Coll Cardiol. 2012 Feb 7;59(6):572-82 - PubMed
  82. Heart Fail Clin. 2011 Jan;7(1):39-45 - PubMed
  83. JAMA. 2014 Feb 5;311(5):507-20 - PubMed
  84. Arch Intern Med. 2007 Dec 10;167(22):2437-42 - PubMed
  85. Circulation. 1998 Aug 25;98(8):731-3 - PubMed
  86. Am J Epidemiol. 1990 Jan;131(1):32-47 - PubMed
  87. Eur J Clin Nutr. 2014 Oct;68(10):1101-6 - PubMed
  88. Circulation. 2006 Aug 15;114(7):e257-354 - PubMed
  89. J Cardiovasc Risk. 2002 Apr;9(2):67-76 - PubMed
  90. J Am Coll Cardiol. 2014 Jul 1;63(25 Pt B):2935-59 - PubMed
  91. Circulation. 2015 Jan 20;131(3):237-44 - PubMed
  92. Nat Clin Pract Endocrinol Metab. 2008 Apr;4(4):215-22 - PubMed
  93. J Am Coll Cardiol. 1995 Aug;26(2):358-64 - PubMed
  94. Diabet Med. 2010 Apr;27(4):436-41 - PubMed
  95. N Engl J Med. 2000 Mar 23;342(12):836-43 - PubMed
  96. Arch Intern Med. 2012 Feb 13;172(3):209-16 - PubMed
  97. J Clin Endocrinol Metab. 2005 Jul;90(7):4004-10 - PubMed
  98. Circulation. 1997 Oct 7;96(7):2468-82 - PubMed
  99. N Engl J Med. 2007 Jun 21;356(25):2591-602 - PubMed
  100. Cardiol Clin. 1998 Feb;16(1):1-8 - PubMed
  101. Circ Cardiovasc Qual Outcomes. 2009 Mar;2(2):63-4 - PubMed
  102. Am Heart J. 2010 Feb;159(2):215-221.e6 - PubMed
  103. J Hypertens. 1999 Oct;17(10):1373-8 - PubMed
  104. Can J Cardiol. 1988 Jul;4 Suppl A:5A-10A - PubMed

Publication Types

Grant support